Status:
COMPLETED
Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR
Lead Sponsor:
Lamm, Steven, M.D.
Collaborating Sponsors:
Solvay Pharmaceuticals
Conditions:
Hypogonadism
Eligibility:
MALE
21-59 years
Brief Summary
Low testosterone may be responsible for "soft" erections in men. The purpose of our study is to see whether the daily application of a testosterone gel to raise testosterone levels will also increase ...
Eligibility Criteria
Inclusion
- Testosterone \<350 ng/dL,
- 21-59 years of age,
- BMI \<30
Exclusion
- Those with carcinoma of the breast or known or suspected carcinoma of the prostate or with known hypersensitivity to any of the ingredients in AndroGel.
- Men will be excluded if they have unstable angina, hypertension, diabetes, heart failure, or coronary artery disease.
- Men will agree to discontinue use of current testosterone replacement, as well as Viagra or any other PDE5 inhibitors for 30 days.
Key Trial Info
Start Date :
December 1 2005
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00425568
Start Date
December 1 2005
Last Update
August 8 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Steven Lamm, M.D.
New York, New York, United States, 10028